Literature DB >> 9280305

Clathrin interacts specifically with amphiphysin and is displaced by dynamin.

H T McMahon1, P Wigge, C Smith.   

Abstract

Amphiphysin is an SH3 domain protein that has been implicated in synaptic vesicle endocytosis. We have recently cloned a second amphiphysin isoform, Amph2 (sequence submitted to GenBank, Y13380). Proteins capable of forming a complex with amphiphysin were isolated from rat brain by using recombinant GST-Amph2 for binding experiments. As well as interacting with dynamin I, the full-length protein bound to a weaker 180-kDa band. Immunoblotting demonstrated this protein to be clathrin. To address whether this is a direct interaction, the clathrin binding to amphiphysin was reconstituted in vitro with purified proteins. The N-terminal domain of Amph2 is sufficient for clathrin binding. Dynamin, which interacts with the SH3 domain of Amph2, displaces clathrin from the N-terminus. We propose a model that may explain how clathrin and dynamin are recruited to non-overlapping sites of the coated pit.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9280305     DOI: 10.1016/s0014-5793(97)00928-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  26 in total

1.  Real-time detection reveals that effectors couple dynamin's GTP-dependent conformational changes to the membrane.

Authors:  Rajesh Ramachandran; Sandra L Schmid
Journal:  EMBO J       Date:  2007-12-13       Impact factor: 11.598

Review 2.  Let's go bananas: revisiting the endocytic BAR code.

Authors:  Britta Qualmann; Dennis Koch; Michael Manfred Kessels
Journal:  EMBO J       Date:  2011-08-31       Impact factor: 11.598

3.  Crystal structure of the alpha appendage of AP-2 reveals a recruitment platform for clathrin-coat assembly.

Authors:  L M Traub; M A Downs; J L Westrich; D H Fremont
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

4.  Crystal structure of the amphiphysin-2 SH3 domain and its role in the prevention of dynamin ring formation.

Authors:  D J Owen; P Wigge; Y Vallis; J D Moore; P R Evans; H T McMahon
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

Review 5.  Systems biology and physical biology of clathrin-mediated endocytosis.

Authors:  Vyas Ramanan; Neeraj J Agrawal; Jin Liu; Sean Engles; Randall Toy; Ravi Radhakrishnan
Journal:  Integr Biol (Camb)       Date:  2011-07-26       Impact factor: 2.192

6.  The NECAP PHear domain increases clathrin accessory protein binding potential.

Authors:  Brigitte Ritter; Alexei Yu Denisov; Jacynthe Philie; Patrick D Allaire; Valerie Legendre-Guillemin; Peter Zylbergold; Kalle Gehring; Peter S McPherson
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

7.  Amphiphysin I but not dynamin I nor synaptojanin mRNA expression increased after repeated methamphetamine administration in the rat cerebrum and cerebellum.

Authors:  Mitsuko Hamamura; Jiro Okouchi; Hidetoshi Ozawa; Yoshihiko Kimuro; Akiko Iwaki; Yasuyuki Fukumaki
Journal:  J Neural Transm (Vienna)       Date:  2012-12-08       Impact factor: 3.575

Review 8.  Alzheimer's disease genetics: from the bench to the clinic.

Authors:  Celeste M Karch; Carlos Cruchaga; Alison M Goate
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

9.  Targeted disruption of the murine Bin1/Amphiphysin II gene does not disable endocytosis but results in embryonic cardiomyopathy with aberrant myofibril formation.

Authors:  Alexander J Muller; Judith F Baker; James B DuHadaway; Kai Ge; George Farmer; P Scott Donover; Raymond Meade; Christian Reid; Reinhard Grzanna; Arthur H Roach; Neelima Shah; Alejandro Peralta Soler; George C Prendergast
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

10.  AMPH-1/Amphiphysin/Bin1 functions with RME-1/Ehd1 in endocytic recycling.

Authors:  Saumya Pant; Mahak Sharma; Kruti Patel; Steve Caplan; Chavela M Carr; Barth D Grant
Journal:  Nat Cell Biol       Date:  2009-11-15       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.